抗癫痫药物的个体化给药算法与治疗药物监测
针对11种常用抗癫痫药物,通过模拟比较五种给药场景(固定剂量、群体药代动力学预测清除率个体化、不同采样方案TDM获取清除率个体化)以达到稳态目标暴露为性能指标进行排序。结果表明,与现行临床指南不同,应结合患者人口学与临床特征及TDM来个体化癫痫治疗。
要点
- 基于模型的给药算法可提高目标暴露达标率并改善治疗反应。
- 与现行指南不同,个体化治疗应结合患者特征与TDM。
- 不同TDM采样方案对个体化给药性能有影响。
核心结论
- 基于模型的给药算法能确保达到目标暴露并改善治疗反应。
- 患者人口学与临床特征应联合TDM用于癫痫个体化治疗,与现行指南不同。
研究设计与样本
- 使用模拟方法,对11种常用抗癫痫药物探索不同治疗场景。
- 每种药物考虑五种场景:固定剂量、群体药代动力学预测清除率个体化、不同采样方案TDM获取清除率个体化。
主要发现
- 以稳态目标暴露达标率为性能指标对五种场景进行排序。
- 不同TDM采样方案获取的个体清除率用于个体化给药。
临床怎么用
- 临床可基于模型给药算法结合患者特征与TDM个体化抗癫痫药物剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pharmacokinetic (PK) models exist for most antiepileptic drugs (AEDs). Yet their use in clinical practice to assess interindividual differences and derive individualized doses has been limited. Here we show how model-based dosing algorithms can be used to ensure attainment of target exposure and improve treatment response in patients. Using simulations, different treatment scenarios were explored for 11 commonly used AEDs. For each drug, five scenarios were considered: 1) all patients receive the same dose. 2) Individual clearance (CL), as predicted by population PK models, is used to personalize treatment. 3-5) Individual CL, obtained by therapeutic drug monitoring (TDM) according to different sampling schemes, is used to personalize treatment. Attainment of steady-state target exposure was used as the performance criterion to rank each scenario. In contrast to current clinical guidelines, our results show that patient demographic and clinical characteristics should be used in conjunction with TDM to personalize the treatment of seizures.
引用
- van Dijkman SC, Wicha SG, Danhof M, et al. Individualized Dosing Algorithms and Therapeutic Monitoring for Antiepileptic Drugs. Clin Pharmacol Ther. 2017. PMID: 28653352. doi:10.1002/cpt.777
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。